Dr. Martens plc (LON:DOCS – Get Free Report) insider Ije Nwokori acquired 176 shares of the stock in a transaction on Tuesday, November 11th. The shares were acquired at an average price of GBX 85 per share, with a total value of £149.60.
Ije Nwokori also recently made the following trade(s):
- On Wednesday, October 15th, Ije Nwokori sold 298,675 shares of Dr. Martens stock. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50.
- On Monday, October 13th, Ije Nwokori acquired 167 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 89 per share, with a total value of £148.63.
- On Wednesday, October 8th, Ije Nwokori purchased 136 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 90 per share, with a total value of £122.40.
Dr. Martens Trading Up 0.1%
LON:DOCS opened at GBX 86.40 on Thursday. The company has a market cap of £834.91 million, a PE ratio of 172.80, a P/E/G ratio of 6.40 and a beta of 0.11. The business’s 50 day moving average is GBX 91.29 and its two-hundred day moving average is GBX 79.33. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. Dr. Martens plc has a 52 week low of GBX 43.02 and a 52 week high of GBX 100.87.
Analysts Set New Price Targets
Check Out Our Latest Research Report on DOCS
Dr. Martens Company Profile
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
Featured Stories
- Five stocks we like better than Dr. Martens
- How to find penny stocks to invest and trade
- Rare Earth Stocks: The Truce That Isn’t a Truce
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Should You Invest in Penny Stocks?
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
